These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2239466)

  • 1. Cerebrospinal fluid dopamine, norepinephrine, and epinephrine concentrations in Parkinson's disease correlated with clinical symptoms.
    Tohgi H; Abe T; Takahashi S; Ueno M; Nozaki Y
    Adv Neurol; 1990; 53():277-82. PubMed ID: 2239466
    [No Abstract]   [Full Text] [Related]  

  • 2. CSF and plasma concentrations of free norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease.
    Eldrup E; Mogensen P; Jacobsen J; Pakkenberg H; Christensen NJ
    Acta Neurol Scand; 1995 Aug; 92(2):116-21. PubMed ID: 7484057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catecholamines in CSF, plasma, and tissue after autologous transplantation of adrenal medulla to the brain in patients with Parkinson's disease.
    Tyce GM; Ahlskog JE; Carmichael SW; Chritton SL; Stoddard SL; van Heerden JA; Yaksh TL; Kelly PJ
    J Lab Clin Med; 1989 Aug; 114(2):185-92. PubMed ID: 2754305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative concentrations of catecholamines in the cerebrospinal fluid and plasma during spinal anesthesia.
    Oehmke MJ; Podranski T; Mann M; Frickey N; Kuhn DF; Hempelmann G
    Acta Anaesthesiol Scand; 2008 Apr; 52(4):487-92. PubMed ID: 18339154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia.
    Engelborghs S; Vloeberghs E; Le Bastard N; Van Buggenhout M; Mariën P; Somers N; Nagels G; Pickut BA; De Deyn PP
    Neurochem Int; 2008 May; 52(6):1052-60. PubMed ID: 18093695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biogenic amines in cerebrospinal fluid and plasma of patients with dementia of Alzheimer type.
    Pinessi L; Rainero I; De Gennaro T; Gentile S; Portaleone P; Bergamasco B
    Funct Neurol; 1987; 2(1):51-8. PubMed ID: 3678940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noradrenaline levels in cerebrospinal fluid of drug-free and pimozide-treated schizophrenic patients.
    Maj M; Arena F; Volpe M; Kemali D
    Acta Neurol (Napoli); 1983 Dec; 5(6):461-7. PubMed ID: 6670602
    [No Abstract]   [Full Text] [Related]  

  • 8. Adrenal medullary transplantation into the brain for treatment of Parkinson's disease: clinical outcome and neurochemical studies.
    Ahlskog JE; Kelly PJ; van Heerden JA; Stoddard SL; Tyce GM; Windebank AJ; Bailey PA; Bell GN; Blexrud MD; Carmichael SW
    Mayo Clin Proc; 1990 Mar; 65(3):305-28. PubMed ID: 2314121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled study of dementia in Parkinson's disease over 54 months.
    Mindham RH; Biggins CA; Boyd JL; Harrop FM; Madeley P; Randall JI; Spokes EG
    Adv Neurol; 1993; 60():470-4. PubMed ID: 8420172
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative study on neurochemistry of cerebrospinal fluid in advanced Parkinson's disease.
    Liu H; Iacono RP; Schoonenberg T; Kuniyoshi S; Buchholz J
    Neurobiol Dis; 1999 Feb; 6(1):35-42. PubMed ID: 10078971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between changes in CSF dopamine turnover and development of dyskinesia in Parkinson's disease.
    Lunardi G; Galati S; Tropepi D; Moschella V; Brusa L; Pierantozzi M; Stefani A; Rossi S; Fornai F; Fedele E; Stanzione P; Hainsworth AH; Pisani A
    Parkinsonism Relat Disord; 2009 Jun; 15(5):383-9. PubMed ID: 19010710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease: epidemiology, (differential) diagnosis, therapy, relation to dementia.
    Oertel WH
    Arzneimittelforschung; 1995 Mar; 45(3A):386-9. PubMed ID: 7763330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Freezing of gait in Parkinson's disease.
    Panisset M
    Neurol Clin; 2004 Oct; 22(3 Suppl):S53-62. PubMed ID: 15501366
    [No Abstract]   [Full Text] [Related]  

  • 14. Monoamine metabolism in the cerebrospinal fluid in Parkinson's disease: relationship to clinical symptoms and subsequent therapeutic outcomes.
    Tohgi H; Abe T; Takahashi S; Takahashi J; Nozaki Y; Ueno M; Kikuchi T
    J Neural Transm Park Dis Dement Sect; 1993; 5(1):17-26. PubMed ID: 8094960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia-parkinsonism.
    Brashear A; Butler IJ; Hyland K; Farlow MR; Dobyns WB
    Ann Neurol; 1998 Apr; 43(4):521-6. PubMed ID: 9546335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Are disturbances in the central metabolism of dopamine specific for Parkinson's syndrome?].
    van Praag HM; Korf J
    Ned Tijdschr Geneeskd; 1971 Mar; 115(12):514-5. PubMed ID: 5546941
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biochemical and clinical correlations in Parkinson's disease].
    Barbeau A
    Rev Neurol (Paris); 1972 Aug; 127(2):253-64. PubMed ID: 4603361
    [No Abstract]   [Full Text] [Related]  

  • 18. Laboratory examinations correlated with severity of dementia.
    Oishi M; Mochizuki Y; Yoshihashi H; Takasu T; Nakano E
    Ann Clin Lab Sci; 1996; 26(4):340-5. PubMed ID: 8800434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and therapy of Parkinson's disease].
    Wittstock M; Benecke R
    MMW Fortschr Med; 2005 May; 147 Spec No 2():28-31. PubMed ID: 15968869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine.
    Peuler JD; Johnson GA
    Life Sci; 1977 Sep; 21(5):625-36. PubMed ID: 904439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.